Radiopharmacueticals, department of radiology nuclear medicine
Ended Purchase Order Awarded Last action
- Contract number
- W81K0025PA273
- Awardee
-
RLS (USA) Inc. UEI UA3GDUKRYSM5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $58,006
Award facts
- Contract value 100% obligated
- $58,006.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Lake Mary, FL 32746, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $58,006 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a $58,006.25 firm fixed-price purchase order to RLS (USA) Inc. for radiopharmaceuticals and related services to support the Department of Radiology Nuclear Medicine. The contract, awarded on October 1, 2025, with an ultimate completion date of September 30, 2026, represents a non-set-aside procurement for time-sensitive medical isotopes and diagnostic imaging agents required for nuclear medicine procedures at military treatment facilities. RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, operates 31 radiopharmacy facilities across 18 states and serves as a critical supplier to both the Defense Health Agency and Department of Veterans Affairs, delivering specialized products including fluorodeoxyglucose F-18, technetium-99m derivatives, gallium-67, and other diagnostic and therapeutic radiopharmaceuticals essential for nuclear medicine imaging and treatment.
RLS (USA) Inc. maintains an extensive portfolio of federal contracts with the Defense Health Agency and multiple Veterans Integrated Service Networks, including a $1.9 million Blanket Purchase Agreement with Naval Medical Center San Diego and numerous indefinite delivery contracts worth millions of dollars extending through 2030. This purchase order reflects the federal government's continued reliance on RLS (USA) Inc.'s capacity to reliably supply specialized radiopharmaceuticals to support diagnostic and therapeutic nuclear medicine services across the military healthcare system. The company's established infrastructure and experience delivering time-sensitive medical products position it as a preferred supplier for radiopharmaceutical procurement within the defense healthcare enterprise.
Quick answers
Who was awarded contract W81K0025PA273?
W81K0025PA273 was awarded to RLS (USA) Inc. by Medical Command (Department of the Army) on October 1, 2025.
How much is contract W81K0025PA273 worth?
The government has obligated $58,006 on W81K0025PA273.
Which agency awarded contract W81K0025PA273?
Medical Command (Department of the Army) awarded W81K0025PA273, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0025PA273 competed?
The extent of competition for W81K0025PA273 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award